Heramed Ltd (HMD) - Cash Flow Conversion Efficiency

Latest as of June 2025: -3.359x

Based on the latest financial reports, Heramed Ltd (HMD) has a cash flow conversion efficiency ratio of -3.359x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.27 Million ≈ $-901.06K USD) by net assets (AU$379.12K ≈ $268.26K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See HMD net asset quality index to measure how much of total assets are equity-financed.

Heramed Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Heramed Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Heramed Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Heramed Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Heramed Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
VisDynamics Holdings Bhd
KLSE:0120
0.003x
Legacy Iron Ore Ltd
AU:LCY
0.095x
Zhejiang Yuancheng Landscape
SHG:603388
0.003x
Farmer Bros. Co
NASDAQ:FARM
-0.125x
Epitomee Medical Ltd
TA:EPIT
-0.416x
Hochschild Mining plc
LSE:HOC
0.304x
Hanwha Chemical Corp Pref
KO:009835
-0.030x
D P Wires Limited
NSE:DPWIRES
0.208x

Annual Cash Flow Conversion Efficiency for Heramed Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Heramed Ltd from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see Heramed Ltd market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 AU$1.72 Million
≈ $1.21 Million
AU$-4.81 Million
≈ $-3.41 Million
-2.807x +76.49%
2023-12-31 AU$466.70K
≈ $330.22K
AU$-5.57 Million
≈ $-3.94 Million
-11.940x -1249.49%
2022-12-31 AU$2.89 Million
≈ $2.05 Million
AU$-2.56 Million
≈ $-1.81 Million
-0.885x +87.90%
2021-12-31 AU$441.88K
≈ $312.66K
AU$-3.23 Million
≈ $-2.29 Million
-7.314x -422.60%
2020-12-31 AU$1.99 Million
≈ $1.41 Million
AU$-2.78 Million
≈ $-1.97 Million
-1.399x -21.16%
2019-12-31 AU$2.39 Million
≈ $1.69 Million
AU$-2.76 Million
≈ $-1.95 Million
-1.155x -183.85%
2018-12-31 AU$3.36 Million
≈ $2.37 Million
AU$-1.37 Million
≈ $-966.34K
-0.407x +85.05%
2017-12-31 AU$201.88K
≈ $142.84K
AU$-549.66K
≈ $-388.92K
-2.723x -71.31%
2016-12-31 AU$872.17K
≈ $617.12K
AU$-1.39 Million
≈ $-980.81K
-1.589x --

About Heramed Ltd

AU:HMD Australia Medical Devices
Market Cap
$27.58 Million
AU$38.98 Million AUD
Market Cap Rank
#23989 Global
#940 in Australia
Share Price
AU$0.04
Change (1 day)
-5.41%
52-Week Range
AU$0.02 - AU$0.05
All Time High
AU$0.32
About

HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It also provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a remote fetal heart rate monitoring solution. The company has a collaboration agreement with Mayo Clinic for the … Read more